Lukman Yusuf

Mr. Lukman Yusuf

College Of health science and technology Jega

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2023
Verified
Book Chapter
Open access
PDF file
ZBZakariyya Muhammad Bello
Zakariyya Muhammad Bello
SASharafudeen Dahiru Abubakar
Sharafudeen Dahiru Abubakar
IKImam Malik Kabir
Imam Malik Kabir
LYLukman Yusuf
Lukman Yusuf
Cervical cancer is the second most common cause of cancer-related death among women that is caused by Human Papillomavirus, a double-stranded virus that leads to cellular alterations in the cervical squamocolumnar junction. Most HPV infections are cleared by the host immune system, while very low cases progress to invasive carcinoma due to persistent infection and other contributory risk factors. Several screening techniques have been devised over the years to detect Human Papillomavirus at an early stage, the most common being the Pap smear test, which is capable of detecting benign cellular changes and also squamous intraepithelial neoplasias. Other important techniques involve visual inspection with acetic acid (VIA), colposcopy, and HPV DNA testing. In addition, recent advances have led to the development of new techniques such as biosensor and bioreceptor technology and loop-mediated isothermal amplification (LAMP). Several methods have been in place to prevent the increased incidence of cervical cancer. Among these is the development of Prophylactic HPV vaccines, which elicit a humoral immune response against about 15 HPV genotypes but have the limitation of not curing an established cancer. Several trials are underway on developing a therapeutic vaccine that will be effective in curing cervical cancer.

13 February 2026 in Cancers
Verified
Journal Article
Open access
PDF file
HAHayat Asaad Al-Ali
Hayat Asaad Al-Ali
Mohamed El-TananiMohamed El-Tanani
Mohamed El-Tanani
Shakta Mani SatyamShakta Mani Satyam
Shakta Mani Satyam
TATalal Al-Qaisi
Talal Al-Qaisi
LYLukman Yusuf
Lukman Yusuf
RKRahmeh Khirfan
Rahmeh Khirfan
Background: Cancer progression is driven by coordinated dysregulation of intracellular transport, proteostasis, and extracellular matrix remodeling. Therapeutic strategies targeting a single pathway often fail due to tumor adaptability and resistance. Drug repurposing offers a promising approach to identify multi-target anticancer agents with established safety profiles. Pimozide, an FDA-approved antipsychotic drug, has recently emerged as a candidate with potential anticancer activity, although its molecular mechanisms remain incompletely understood. Objectives: This study aimed to investigate the anticancer effects of pimozide across breast, colorectal, and pancreatic cancer models, with a specific focus on its modulation of Ran GTPase signaling, Skp1–Cullin–F-box (SCF) ubiquitin ligase components, and matrix metalloproteinase-2–mediated extracellular matrix remodeling. Methods: Cell viability was assessed using MTT assays in MDA-MB-231, MCF-7, HT-29, and PanC-1 cell lines. Quantitative real-time polymerase chain reaction was employed to evaluate the expression of Ran, MMP2, Cullin1, Rbx1, SKP2, and FBXW10 following pimozide treatment. Molecular docking and MMGBSA analyses were performed to characterize binding interactions between pimozide and selected target proteins. Results: Pimozide induced concentration-dependent cytotoxicity in all tested cell lines with variable IC50 values. Treatment resulted in consistent downregulation of Ran and MMP-2 across cancer types, alongside context-dependent modulation of SCF complex components. Notably, FBXW10 exhibited the strongest binding affinity to pimozide in silico, suggesting functional disruption of ubiquitin-mediated proteostasis. Conclusions: Pimozide exerts anticancer effects through coordinated disruption of nucleocytoplasmic transport, proteostasis regulation, and matrix remodeling. These findings support the repositioning of pimozide as a multi-target anticancer agent and provide a mechanistic foundation for further translational investigation.

1 September 2026 in Journal of Sports Science and Medicine
Verified
Journal Article
Open access
PDF file
SASameer Badri AL-MHANNA
Sameer Badri AL-MHANNA
BFBarry A. Alan Franklin
Barry A. Alan Franklin
Zacharias Papadakis, FACSM, ACSM-EP, ACSM-ACSZacharias Papadakis, FACSM, ACSM-EP, ACSM-ACS
Zacharias Papadakis, FACSM, ACSM-EP, ACSM-ACS
Stuart PhillipsStuart Phillips
Stuart Phillips
JJJohn M. M. Jakicic
John M. M. Jakicic
Alexios BatrakoulisAlexios Batrakoulis
Alexios Batrakoulis
To evaluate the effects of aerobic exercise (AE) versus resistance training (RT) on cardiometabolic health-related outcomes in patients with type 2 diabetes mellitus and concurrent obesity (diabesity). Systematic review and meta-analysis of randomized controlled trials (RCTs). PubMed, Web of Science, Scopus, ScienceDirect, Cochrane Library, and Google Scholar databases were searched from inception up to April 2026. RCTs comparing AE and RT for a minimum duration of two weeks. Participants were adults with diabesity. A total of 23 RCTs qualified, involving 1, 184 patients (58/42 women/men ratio; age range: 30-70 years; body mass index: 32.1 ± 6.6 kg/m2). AE appears to be more efficacious than RT in reducing fasting blood glucose (mean differences (MD) = -0.89 mmol/L, 95% CI: -1.62 to -0.16; I2 = 0%) and increasing cardiorespiratory fitness (MD = 1.78 mL/kg/min, 95% CI: 0.38 to 3.18; I2 = 66%). However, AE led to a greater increase in body fat (MD = 0.34%, 95% CI: 0.10 to 0.57; I2 = 1%) and less fat-free mass retention (MD = -0.86 kg, 95% CI: -1.46 to -0.26; I2 = 37%) compared with RT. For selected cardiometabolic health-related outcomes, including anthropometrics, blood lipids, and hemodynamics, no statistically significant between-group difference was detected. The overall certainty of the evidence across outcomes ranged from high to very low, with most being moderate. In adults with diabesity, AE appears to provide greater benefits for FBG and CRF, whereas RT appears more favorable for preserving FFM and improving BF. For the majority of cardiometabolic outcomes, the two modalities exhibit analogous effects. The present findings support a goal-directed and complementary approach to exercise prescription, as opposed to a one-modality-fits-all model, for the improvement of cardiometabolic health in patients with diabesity.